Chapter 29: Promoting Premenstrual, Perimenopausal, and Menopausal Health

Premenstrual syndrome and premenstrual dysphoric disorder represent cyclical conditions occurring during the luteal phase of menstruation, with symptoms ranging from physical manifestations such as bloating and breast tenderness to affective symptoms including mood disturbances and anxiety. While the precise etiology remains unclear, current understanding points to multifactorial origins involving genetic factors, hormonal sensitivity, and neurotransmitter dysregulation, particularly involving serotonin. Nursing assessment relies on prospective symptom tracking over multiple cycles to establish diagnostic patterns. Management strategies integrate nonpharmacological approaches including aerobic exercise, stress reduction techniques, and dietary modification alongside pharmacological interventions such as nonsteroidal anti-inflammatory drugs, hormonal contraceptives, and selective serotonin reuptake inhibitors for emotional symptom relief. The menopausal transition, or climacteric, encompasses the perimenopause phase characterized by irregular hormone fluctuations and menses lasting approximately four years, culminating in menopause defined as twelve consecutive months without menstruation. Vasomotor symptoms including hot flashes and night sweats, along with genitourinary changes such as vaginal atrophy and urinary dysfunction, represent common presentations during this transition. The decline in estrogen during and after menopause significantly elevates risks for cardiovascular disease and osteoporosis, requiring nurses to promote preventive health behaviors and appropriate screening measures such as bone mineral density testing. Hormone therapy options including estrogen therapy for hysterectomized women and combined estrogen-progestogen therapy for those with intact uteri offer symptom management, though contraindications and individual risk profiles necessitate careful counseling. Complementary approaches and bioidentical hormone preparations present additional management considerations, though their regulatory status and evidence base require critical nursing evaluation and patient education.